Abstract
The patient was a 50-year-old female with peritoneal metastasis of Type 4 gastric cancer. She underwent a relative curative resection with total gastrectomy and peritonectomy. Postoperative chemotherapy with 5'-DFUR following 5-FU and CDDP was performed. Thirteen months after surgery, cancer recurrence was suspected due to elevated levels of the serum tumor markers carcinoembryonic antigen (8.9 ng/ml) and alpha fetoprotein (85.8 ng/ml). She was additionally treated with UFT 300 mg/day and Lentinan 2 mg/week. The serum tumor markers decreased gradually returned to normal levels. At 5 years and 8 months after surgery, she is alive without any sign of recurrence.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Biomarkers, Tumor / blood
-
Carcinoembryonic Antigen / blood
-
Carcinoma, Signet Ring Cell / drug therapy*
-
Carcinoma, Signet Ring Cell / secondary
-
Carcinoma, Signet Ring Cell / surgery
-
Chemotherapy, Adjuvant
-
Drug Administration Schedule
-
Drug Combinations
-
Female
-
Gastrectomy
-
Humans
-
Lentinan / administration & dosage
-
Middle Aged
-
Neoplasm Invasiveness
-
Peritoneal Neoplasms / drug therapy*
-
Peritoneal Neoplasms / secondary
-
Peritoneal Neoplasms / surgery
-
Peritoneum / surgery
-
Stomach Neoplasms / drug therapy*
-
Stomach Neoplasms / pathology
-
Stomach Neoplasms / surgery
-
Survivors
-
Tegafur / administration & dosage
-
Uracil / administration & dosage
-
alpha-Fetoproteins / analysis
Substances
-
Biomarkers, Tumor
-
Carcinoembryonic Antigen
-
Drug Combinations
-
UFT(R) drug
-
alpha-Fetoproteins
-
Tegafur
-
Lentinan
-
Uracil